Showing results (11-20 of 53) with videos related to
Sort By:
Pageof 6
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|November 28, 2019
[Application of Simultaneous Integrated Boost Intensity Modulated Radiotherapy in Locally Advanced Non-small Cell Lung Cancer]Jing You, Dan Yang, Dongming Li, et al.Journal of Thoracic Disease|September 15, 2025
Survival outcomes of thoracic radiotherapy in addition to first-line immunotherapy in metastatic non-small cell lung cancer: a multicenter, propensity score-matched analysisZhe Du, Yuting Zhao, Lehui Du, et al.Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|September 20, 2011
[Role of EGFR mutation status in patients with stage III non-squamous non-small cell lung cancer treated with chemoradiotherapy]Fuhai Li, Hua Bai, Xia'nan Li, et al.Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|January 21, 2017
[A Phase I/II Study of Chemotherapy Concurrent with Twice-daily Radiotherapy Schedules by Intensity Modulated Radiation Therapy Using Simultaneous Integrated Boost for Limited-stage Small Cell Lung Cancer]Jing You, Huiming Yu, Maxiaowei Song, et al.Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|January 21, 2017
[Phase I Study of Etoposide and Cisplatin Chemotherapy Dose Escalation with Concurrent Twice-daily Radiotherapy for Patients with Limited-stage Small Cell Lung Cancer]Jing You, Huiming Yu, Maxiaowei Song, et al.Frontiers in Oncology|July 5, 2021
Hypofractionated Volumetric-Modulated Arc Radiotherapy for Patients With Non-Small-Cell Lung Cancer Not Suitable for Surgery or Conventional Chemoradiotherapy or SBRTJunyue Shen, Dan Yang, Mailin Chen, et al.Medical Physics|June 1, 2022
A prediction model for dosimetric-based lung adaptive radiotherapyChaoqiong Ma, Zhen Tian, Ruoxi Wang, et al.Thoracic Cancer|February 4, 2020
Stereotactic ablative radiotherapy of 60 Gy in eight fractions is safe for ultracentral non-small cell lung cancerDan Yang, Jianing Cui, Jun Zhao, et al.Thoracic Cancer|February 16, 2020
Cone-beam CT radiomics features might improve the prediction of lung toxicity after SBRT in stage I NSCLC patientsQingjin Qin, Anhui Shi, Ran Zhang, et al.Frontiers in Oncology|April 30, 2026
Salvage definitive or hypofractionated radiotherapy for oligometastatic recurrence after durvalumab consolidation in limited-stage small-cell lung cancer: a two-case reportJiahui Shan, Jiayi Yu, Dan Yang, et al.Pageof 6